Innovation Pharmaceuticals Inc (IPIX)

[BioTechMaven]

The true answer is if they get a partnership before Prurisol results, and that partnership is for a Brilacidin indication, then the correct way to interpret things is that that one partnership just validated Brilacidin as a potent multi indication drug. The first partnership is the monkey off the back that should be a watershed moment for share price, validation, and ushering in the era of partnerships. People refer to Brilacidin as a potential gold mine. Let’s run with that analogy. If you were a miner in the California gold rush and found a nugget in the stream , would you abandon the search, or mine the source?

Fools often exit early only to lose the maturation of a pipeline. If OM is successful in the coming weeks you have a phase 3 ready asset that could command $500M or more in annual revenue. If they land an IBD partner and are successful in a larger trial, you have an asset worth literally billions. If they land a parter for absssi, equally, a drug with near billion rev potential. And then there’s atopic Derm and other extensions.

Think like a miner.

Then, there’s Kevetrin and Prurisol.

At .80 cents and $110M market cap, if OM is successful, and a first partnership formed, the true and fair value for the mine should be $500M plus.

Need to pass the OM test first, which will determine whether the mine is safe. I’m very closely watching these results, as for me, they will determine whether I should go completely bonkers all in with another couple seven figures load, especially if it can be snuck in before the other miners show up.